STOCKS TELEGRAPH

Author: ST Staff

  • Why Dogness (International) Corporation (DOGZ) stock pop up in the after-hours on Monday?

    Why Dogness (International) Corporation (DOGZ) stock pop up in the after-hours on Monday?

    Dogness (International) Corporation (DOGZ) shares surged 10.31% in after-market on Monday, June 14, 2021, and closed the day at $2.14 per share. Earlier, DOGZ’s stock lost 5.37% in Monday’s normal session and closed at $1.94. DOGZ shares have risen 12.14% over the last 12 months, and they have moved up 17.58% in the past week. Over the past three months, the stock has lost 2.51%, while over the past six months, it has added 4.86%.

    Dogness Smart Pet Products in Costco

    On June 10, 2021, Dogness Corporation announced that Costco Wholesale Corporation will feature Dogness in its new Little Rock, AR, and Moore, OK stores, with a larger-scale rollout planned for October to prepare for the 2021 holiday season. The new stores will feature Dogness smart pet products including its Smart Treat Dispenser, Smart Water Fountain Plus, and Smart Cam iPet Robot.

    Recent financial results

    On June 4, 2021, Dogness Corporation released its unaudited financial results for the six months ended December 31, 2020.

    Financial highlights for the six months

    • Dogness Corporation reported revenue of $12.2 million for the six months ended December 31, 2020, compared to $11.5 million for the same period last year.
    • The cost of revenues was approximately $7.5 million for six months ended December 31 2020 compared to $7.7 million for six months ended December 31
    • Gross profit was approximately $4.8 million for the six months ended December 31, 2020, compared to $3.8 million for the six months ended December 31. 2019.
    • As of December 31, 2020, the Company had a $2.3 million balance of cash and short-term investments.

    Large Order from Petco

    OnMay 27, 2021, Dogness International Corporation received a large follow-on order from Petco, expanding the availability of the Company’s 6L programmable automatic dog/cat feeders across Petco’s 1,600 retail stores.

    The exceptional surge in China e-commerce sales

    On April 8, 2021, Dogness announced that its e-commerce sales in China have increased 24 times due to its new smart pet product line for the calendar year 2020, as compared to the calendar year 2019.

    Silong Chen, Chairman and Chief Executive Officer of DognessSilong Chen said that Dogness established itself as a leading brand for pet parents seeking innovative, high-quality products, including our expanded line of enhanced pet IoT solutions and smart products.

    New Smart GPS Pet Tracker

    On March 2, 2021, Dogness launched the new state-of-the-art smart GPS pet tracker boasting real-time positioning with pinpoint accuracy. The company is looking for initial delivery in the second quarter of 2021.

    The GPS tracker has a built-in 4G SIM card for high location accuracy and speed. It comes with standard Qi fast and wireless charging support and also its new high-capacity battery provides more than a week of operation per charge

    The closing of share sales offer

    On January 20, 2021, Dogness Corporation announced the closing sales offer of,455,130 common shares for $2.15 and Class A warrants to purchase an aggregate of 1,727,565 common shares.  The offer will raise approximately $7.4 million in gross proceeds from the sale which will be used for working capital and general business purposes.

    The Class A and placement agent warrants are exercisable at $2.70 per share.

    Conclusion

    Well, as of this writing there is no recent news that could justify its turnaround in the after-market on Monday.

  • Why DHI Group Inc. (DHX) stock turnaround in the after-hours on Monday?

    Why DHI Group Inc. (DHX) stock turnaround in the after-hours on Monday?

    DHI Group Inc. (DHX) shares surged 10.42% in after-market on Monday, June 14, 2021, and closed at $3.71 per share. Earlier, in Monday’s morning session, DHX’s stock lost 7.69% to close Monday’s session at $3.36. DHX shares have risen 27.76% over the last 12 months, and they have moved up 4.02% in the past week. Over the past three months, the stock has lost 2.33%, while over the past six months, it has jumped 58.49%.

    Let’s discuss its recent news and developments.

    Participation in the investor conferences

    DHI Group, Inc participated in the Summer Solstice Best Ideas from the Buy-Side Conference which held on June 2, 2021. The company was presented by Chief Executive Officer, Art Zeile, and Chief Financial OfficerKevin Bostick.

    DHI participated in the Sidoti & Co. Virtual Microcap Conference which held on May 19-20th, 2021. The company was presented by Chief Executive Officer, Art Zeile, and Chief Financial Officer Kevin Bostick.

    Recent financial results

    On May 5, 2021, DHI Group, Inc released its financial results for the first quarter ended March 31, 2021.

    Q1 2021 financial highlights

    • DHI Group reported total revenue of $32.6 million in Q1 2021 compared to $36.6 million in Q1 2020.
    • Net income was $2.7 million in Q1 2021 compared to a net loss of $6.6 million in the year-ago quarter.
    • Earnings per diluted share were $0.05 in Q1 2021, compared to a loss of $0.13in Q1 2020.
    • Operating cash flow was $6.4 million in Q1 2021, compared to $2.9 million in the year-ago quarter.
    • Total operating expenses were $32.14 million in Q1 2021 compared to $41.9 million in Q1 2020.
    • Adjusted EBITDA was $7.3 million for Q1 2021 compared to $7.5 million in Q1 2020.
    • On March 31, 2021, the company had cash of $7.3 million and net debt was $12.7 million.

    Release of IntelliSearch™

    On April 21, 2021, Dice, a DHI Group, Inc. brand announced the release of IntelliSearch™ Jobs and Alerts, which automatically deliver­­ the most relevant opportunities to tech professionals based on their Dice Candidate Profile.

    New Calendar Integration

    On March 17, 2021, DHI Group, Inc announced that ClearanceJobs, the leading career marketplace for professionals with security clearances, has released a new product integration called Meetings, allowing candidates and recruiters to connect seamlessly. The new product integration will reduce recruiter and candidate missed opportunities, saving significant time and making meaningful connections easier.

    Conclusion

    We have no recent news or developments as of this writing which we could link with its flipped on Monday. We Hope that DHX will continue its surge on Tuesday as well.

  • After Hours Trading, Why Did The TACO Stock Gain Traction?

    The shares of Del Taco Restaurants Inc. (TACO) rose 19.7% in after-market session to trade at $12.7 at last check. In Monday’s session, Del Taco stock lost -0.93% to close at $10.61.

    The volume of TACO stock remained at 0.12 million shares, which was below the average daily volume of 0.31 million shares over the last 50 days. Over the past 12 months, TACO shares have gained 67.61%, and they have advanced by 4.95% over the past week. TACO stock rose in absence of current news, but recent events can now be used to get a better understanding of the company.

    What’s going on at TACO lately?

    Every Del Taco restaurant has a cook setting that prepares fresh burritos and fries in a working kitchen, providing a variety of authentic Mexican and American favorites at great prices. At its approximately 600 restaurants located throughout 16 states, TACO today serves more than three million guests per week. In order to ensure that food at TACO is of the highest quality and value for the money they charge, TACO cooks, chops, shreds, and grills menu items from scratch.

    Last week, Del Taco celebrated its Crispy Chicken year with its Crispy Chicken summer menu. The menu features the widest variety of items and flavors available in the quick service category. TACO also this month announced the opening of its newest restaurant in Melbourne, Florida located at 2936 Sarno Road. The opening is the first Del Taco for franchisees Navdeep Bassi and Aman Singh as the brand continues to expand in Florida with several more restaurants scheduled to open through 2022.

    Are TACO customers getting anything new?

    There are plenty of classic Del Taco (TACO) menu items on offer throughout the year in Florida. In addition to more topping choices, more flavor, and a better value, TACO’s Crunchtada now offers a 6 1/2 inch tortilla topped with a large selection of freshly fried toppings.

  • Here is why Vroom Inc. (VRM) stock turnaround in the after-market on Monday?

    Here is why Vroom Inc. (VRM) stock turnaround in the after-market on Monday?

    Vroom Inc. (VRM) shares declined 4.87% in after-market on Monday, June 14, 2021, and closed the day at $42.99 per share.  Earlier, VRM’s stock gained 2.15% to close Monday’s session at $45.19 per share. VRM shares have risen 5.02% over the last 12 months, and they have moved up 4.17% in the past week. Over the past three months, the stock has gained 20.73%, while over the past six months, it has added 32.91%.

    Let’s see what’s going on with VRM?

    Convertible Senior Notes Offer

    On June 14, 2021, Vroom, Inc announced its intention to offer, $500,000,000 aggregate principal amount of convertible senior notes due 2026 in a private offering to qualified institutional buyers. Vroom also expects to grant the initial purchasers of the notes an option to purchase, for settlement within 13 days from, and including, the date the notes are first issued, up to an additional $75,000,000 aggregate principal amount of notes.

    Last Mile Concierge Experience to Dallas Locals

    On May 27, 2021, Vroom, Incopened a new Dallas hub and a more customized driveway experience for nearly 7 million people in over 1,000 zip codes within a 70-mile radius. Vroom is now offering an experience that includes a more personalized concierge service where customer advocates transport cars directly to car buyers’ driveways on Vroom-branded trucks and show them how to use their new vehicles.

    Vroom facing legal actions and lawsuits

    Several class-action lawsuits have been filed by many law firms against the company and VRM is facing legal challenges.

    On May 21, 2021, Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders.

    the complaint is that defendants made materially false and/or misleading statements and/or failed to disclose that Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

    Recent financial results

    On May 13, 2021, Vroom, Inc released its financial results for the first quarter ended March 31, 2021.

    Q1 2021 financial highlights

    • Vroom reported a net loss of $$77.2 million for Q1 2021, compared to $41.05 million in Q1 2020.
    • Net loss per share, basic and diluted was $0.57 per share in Q1 2021 compared to $4.85 per share in Q1 2020.
    • Total revenue was $591.1 million in Q1 2021 compared to $375.8 million in Q1 2020.
    • The total gross profit was $36.2 million in Q1 2021 compared to $18.39 million in Q1 2020.
    • Selling, general and administrative expenses were $109.1 million in Q1 2021 compared to $58.38 million in Q1 2020.
    • Adjusted EBITDA was $72.6 million in Q1 2021 compared to $39.2 million in Q1 2020.

    Conclusion

    The convertible senior note offer could be the reason either behind its loss or gains on Monday as there is no other recent news.

  • Why PDS Biotechnology Corporation (PDSB) stock lost its positivity in Monday’s after-market?

    Why PDS Biotechnology Corporation (PDSB) stock lost its positivity in Monday’s after-market?

    PDS Biotechnology Corporation (PDSB) shares declined 19.05% in after-market on Monday, June 14, 2021, and closed that day at $10.41 per share. Earlier, PDSB’s stock gained 6.63% in normal Monday’s trading session. PDSB shares have risen 916.60% over the last 12 months, and they have moved up by 36.81% in the past week. Over the past three months, the stock has gained 135.53%, while over the past six months, it has added 489.91%.

    Let’s discuss its recent developments briefly

    The proposed offering of Common Stock

    On June 14, 2021, PDS Biotechnology Corporation commenced an underwritten public offering of shares of its common stock. All of the shares of common stock to be sold in the offering will be offered by PDS Biotech.

    Underwriters will get a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

    Oncology Research and Development Day

    PDS Biotechnology Corporation will host an Oncology R&D Day for analysts, investors, and the scientific community on Wednesday, June 16, 2021.

    Oncology R&D Day will focus on the Company’s advancements in its ongoing preclinical and clinical work and will feature presentations from:

    • Frank Bedu-Addo, President and CEO, PDS Biotech
    • Lauren V. Wood, Chief Medical Officer, PDS Biotech
    • Jeffrey Schlom, Chief of the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
    • Julius Strauss, Principal Investigator, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health
    • Caroline Jochems, Staff Scientist, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institute of Health

    Presentation of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study 

    On June 08, 2021, PDS Biotechnology Corporation presented the interim data for PDS0101from the Phase 2 trial led by the National Cancer Institute (NCI), of the National Institutes of Health (NIH), at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.

    Data from a total of 25 patients were available as of the time of presentation submission in which, 100% (25/25) of patients enrolled had failed chemotherapy treatment.

    96% (24/25) of patients enrolled had failed both chemotherapy and radiation treatment and 56% (14/25) of patients enrolled had failed checkpoint inhibitor therapy (checkpoint inhibitor refractory).

    Joining Russell Microcap® Index

    On June 07, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation announced that the company is set to join the Russell Microcap® Index after the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, 2021.

    Partnership with Head and Neck Cancer Alliance (HNCA)

    On May 27, 2021, PDS Biotechnology announced a partnership with the Head and Neck Cancer Alliance (HNCA). This collaboration will raise awareness of new and developing treatment options, including available clinical trials, for patients with HPV-attributed head and neck cancer diagnoses.

    Conclusion

    The proposed offer of its common stock could be the reason behind its gain or loss on Monday as there is no other recent news. We have to wait and see how PDSB performs on Tuesday.

  • Here is why Rapt Therapeutics Inc (RAPT) stock skyrocketed on Monday?

    Here is why Rapt Therapeutics Inc (RAPT) stock skyrocketed on Monday?

    RAPT Therapeutics Inc. (RAPT) shares gained 13.77% in after-market on Monday, June 14, 2021, and closed the day at $45.53 per share. Earlier, RAPT’s stock soared 115.51% to close Monday’s normal trading session at $40.02 per share. RAPT shares have risen 85.97% over the last 12 months, and they have moved up 116.91% in the past week. Over the past three months, the stock has gained 76.22%, while over the past six months, it has added 71.54%.

    Let’s see is there any recent development behind its exceptional surge?

    Proposed Public Offering of Common Stock

    On June 14, 2021, RAPT Therapeutics, Inc commenced an underwritten public offering of $125 million of its common stock. RAPT also providing a 30-day option to purchase up to an additional $18.75 million of its common stock on the same terms and conditions.

    Positive Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis

    On June 14, 2021, RAPT Therapeutics, Inc. reported positive topline results from its randomized placebo-controlled Phase 1b clinical trial of RPT193 as monotherapy in 31 patients with moderate-to-severe atopic dermatitis (AD).

    patients with moderate-to-severe AD who received RPT193 showed a 36.3% improvement from baseline in the Eczema Area and Severity Index (EASI) score, after four weeks of treatment.

    Participation in the recent health conference

    RAPT Therapeutics recently participated in a fireside chat at the UBS Global Healthcare Virtual Conference which held on Monday, May 24, 2021.

    The company was presented by President and Chief Executive Officer, Brian Wong, M.D., Ph.D.

    Recent financial results

    On May 11, 2021, RAPT Therapeutics, Inc released its financial results for the first quarter ended March 31, 2021.

    Q1 2021 financial highlights

    • RAPT Therapeutics suffered a net loss of $16.5 million for Q1 2021, compared to $13.1 million for the first quarter of 2020.
    • Net loss per share, basic and diluted was $0.66 per share in Q1 2021 compared to $0.56 per share in Q1 2020.
    • Research and development expenses were $13.8 million in Q1 2021, compared to $10.7 million for the same period in 2020.
    • General and administrative expenses were $4.0 million in Q1 2021, compared to $3.3 million for the same period of 2020.
    • The Company had cash and cash equivalents and marketable securities of $98.4 million on March 31, 2021.

    Conclusion

    The RAPT stock rallied on Monday after the company made two important announcements. The positive trial results and public offering of its common stock took the stock to new heights. The RAPT stock can continue its surge on Tuesday as well.

  • Why Eloxx Pharmaceuticals Inc (ELOX) stock performed well on Monday?

    Eloxx Pharmaceuticals Inc. (ELOX) shares surged 15.58% in after-market on Monday, June 14, 2021, and closed the day at $2.3 per share. Earlier, ELOX’s stock gained 4.74% in a normal trading session on Monday and closed at $1.99. ELOX shares have fallen 33.22% over the last 12 months, and they have moved up 5.85% in the past week. Over the past three months, the stock has lost 48.71%, while over the past six months, it has shed 33.44%.

    Let’s have a look at its recent developments.

    Funding award for the development of Ribosome Modulating Agents

    On May 27, 2021, Eloxx Pharmaceuticals, Inc received an award of up to $2.6M from the Cystic Fibrosis Foundation, to help to identify optimized oral RMAs for further development in the treatment of cystic fibrosis (CF) patients with nonsense mutations.

    Closing Public Offering of Common Stock

    On May 18, 2021, Eloxx Pharmaceuticals, Inc closed an underwritten public offering of 38,333,334 shares of common stock at a public offering price of $1.35 per share. The closing included the full exercise of the underwriters’ option to purchase an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts, and commissions.

    The gross proceeds of approximately $51.75 million are expected from the offer.

    Recent financial results

    May 06, 2021, Eloxx Pharmaceuticals, Inc released its financial results for the three months ended March 31, 2021.

    Q1 2021 financial highlights

    • Eloxx Pharmaceuticals suffered a net loss of $8.7 million or $0.22 per share for Q1 2021 compared to a net loss of $13.9 million, or $0.35 per share in Q1 2020.
    • Research and development expenses were $4.1 million for the three months ended March 31, 2021, compared to $4.8 million inQ1 2020.
    • General and administrative (G&A) expenses were $4.3 million for the three months ended March 31, 2021, compared to $5.0 million in Q1 2020.
    • The company had cash and cash equivalents of $18.2 million on March 31, 2021.

    Update about Phase 2 Clinical Studies for Cystic Fibrosis

    On April 29, 2021, Eloxx Pharmaceuticals, Inc announced the addition of a fifth treatment arm in the ongoing global Phase 2 clinical program for ELX-02 for the treatment of cystic fibrosis (CF) in patients with at least one G542X allele.

    The fifth treatment arm will evaluate the safety of ELX-02 in combination with Kalydeco (ivacaftor), for the treatment of cystic fibrosis in patients who have at least one mutation in their CF gene amenable to ivacaftor.

    Conclusion

    Well, s of this writing, there is no recent news or developments behind ELOX’s better performance on Monday.

  • How Come ContextLogic (WISH) Stock Is Rallying Today?

    As of last check, the price of ContextLogic Inc. (Nasdaq:WISH) shares was up 15.90% to $11.59 after closing at $10.00 on Friday. ContextLogic stock was fluctuating between $9.94 and $11.79. A total of 128.86 million shares were exchanged, higher than WISH stock’s year-to-date average daily volume of 15.14 million.

    WISH has gained 20.63% in the last week, but has lost -46.35% over the past quarter. Today, the announcement that ContextLogic has partnered with a leading e-commerce platform boosted the WISH stock.

    Who is ContextLogic partnered with?

    As the fastest-growing global ecommerce platform headquartered in San Francisco and founded in 2010, ContextLogic connects millions of value-conscious shoppers from over 100 countries to over half a million merchants around the world. As part of its mission to create an engaging and personalized shopping experience for its users, WISH combines technology and data science capabilities with an innovative mobile discovery platform.

    A partnership between ContextLogic and popular e-commerce platform PrestaShop was announced today.

    • WISH will enable more than 300,000 merchants and brands on the PrestaShop platform to sell to millions of customers quickly and easily.
    • With this new direct integration module, PrestaShop merchants can connect directly to WISH’s merchant dashboard as part of the PrestaShop platform.
    • Products and orders will be synchronized between PrestaShop and WISH through the module.
    • Additionally, PrestaShop merchants will have access to marketing and sales support as well as a number of special incentives.

    Will the partnership benefit WISH?

    “Trusted Partner” status will be granted to ContextLogic (WISH) on PrestaShop, as well as access to special landing pages for merchants. As a result of this partnership, WISH will provide Prestashop merchants with a global platform to conduct business and will be able to provide its own customers with even more quality merchants and brands.

  • What Is Pushing The inTEST (INTT) Stock Price Up Today?

    The stock of inTEST Corporation (NYSE:INTT) was trading at $16.95 in current market at the time of writing. inTEST stock closed previous session at $14.63. Over the last year, INTT stock has gained 347.40%, and over the last week, it has fallen by -2.86%. INTT stock has been rising after appointing a new Chief Financial Officer.

    INTT has appointed whom?

    inTEST is a global provider of innovative test and process solutions for use across many different industries. These include automotive, aerospace, electronics, medical, semiconductors, and telecommunications.

    INTT builds robust cash flow and profits for its customers while solving thermal, mechanical, and electronic challenges backed by decades of engineering expertise. Through digital integration and acquisition of complementary businesses, INTT is able to maximize its business operations and build value for shareholders.

    After close of the market on Friday, inTEST announced the appointment of Duncan Gilmour as Chief Financial Officer, Treasurer and Secretary, effective June 14, 2021.

    Hugh T. Regan Jr., who retired from INTT after 25 years of service, will be succeeded by Mr. Gilmour. Mr. Regan has agreed to provide consulting services to INTT for some time.

    From INTT’s perspective:

    Mr. Gilmour will oversee INTT’s global finance organization and finance activities as CFO. inTEST (INTT) see Duncan’s appointment as driving forward the company’s vision and growth strategy.

     

  • Bit Digital, Inc. (BTBT) Stock Prices Surge Following Announcement of Strategic Partnership with Digihost Amid Meme Stock Craze

    Bit Digital, Inc. (BTBT) stock prices skyrocketed by a massive 26.16% shortly after market trading commenced on June 14th 2021, bringing the price up to USD$9.77 early on in the trading day.

    Meme Stock Phenomenon

    With the recent proliferation of the meme stock craze taking over stock markets, akin to the GME and AMC episodes from earlier in the year, BTBT seems to be the latest target of the meme stock phenomenon. In the absence of any significant news or developments, the recent surge in PROG stock prices is likely to be attributable to the coordinated pump by investors who are users of the popular social media platform, Reddit.

    Agreement with Digihost

    The company recently announced entering into a strategic co-mining agreement with Digihost Technology Inc (DGHI). As per the agreement, DGHI will provide certain premises to BTBT to facilitate the operation and storage of a 20 MW Bitcoin mining system that will be delivered by BTBT. DGHI will also facilitate the provision of services to maintain the premises for a term of two years. The collaborative efforts of both companies are forecasted to result in an increased generation of hashrate in the amount of almost 400 PH between the two.

    Terms of Agreement

    As per the agreement, DGHI will be responsible or the provision of power for the operation of the Miners, as well as for management services that will be essential in maintaining the planned 95% uptime on the Miners. In return, DGHI will be paid a very competitive rate for power. The two companies will also participate in a profit sharing arrangement based on a fixed distribution formula. The delivery and installation of the Miners is expected for the fourth quarter of the fiscal year 2021.

    Scope of Agreement

    The company expects an increase in hashrate of 400 PH between them, based on current Bitcoin metrics, which will signal a massive collaborative success on the part of the joint venture. BTBT continues to expand its business strategy through the expansion of the company’s mining infrastructure, vertical integration of low-cost and green sources of energy, strategic partnerships within the blockchain sector, and geographic diversification across North America. These steps serve to strategically operating the business in regions where the carbon footprint being generated is minimal or non-existent.

    Future Outlook for BTBT

    Armed with a potentially lucrative strategic partnership, as well as the fortuitous surge in the value of their equity, BTBT is poised to capitalize on the opportunities presented to it. The company is keen to continue its trajectory of success and usher in more organic growth over the long-term. Current and potential investors are hopeful that the management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.